Clinical Trial Update: A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This entry reports a Phase II trial of Velcade (bortezomib) in patients with Stage IIIB or IV non-small cell lung cancer, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER | Phase 2 | Status: TERMINATED